These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7705670

  • 1. A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
    Resnik E, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT.
    Gynecol Oncol; 1995 Mar; 56(3):370-5. PubMed ID: 7705670
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
    Cass I, Resnik E, Chambers JT, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE.
    Gynecol Oncol; 1996 Jun; 61(3):309-14. PubMed ID: 8641607
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jun; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY, Diéras V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Scholl SM, Garcia-Giralt E, Pouillart P.
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M, Kornek GV, Schratter-Sehn AU, Zach M, Schoder M, Raderer M, Rosen H, Schiessel R, Scheithauer W.
    Cancer; 1996 Oct 15; 78(8):1646-50. PubMed ID: 8859175
    [Abstract] [Full Text] [Related]

  • 11. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
    Long HJ, Cross WG, Wieand HS, Webb MJ, Mailliard JA, Kugler JW, Tschetter LK, Kardinal CG, Ebbert LP, Rayson S.
    Gynecol Oncol; 1995 May 15; 57(2):235-9. PubMed ID: 7729741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
    Chambers JT, Chambers SK, Kohorn EI, Carcangiu ML, Schwartz PE.
    Gynecol Oncol; 1996 Mar 15; 60(3):438-42. PubMed ID: 8774654
    [Abstract] [Full Text] [Related]

  • 15. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A, Rare Cancer Network.
    Gynecol Oncol; 2008 Feb 15; 108(2):298-305. PubMed ID: 18096209
    [Abstract] [Full Text] [Related]

  • 16. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L.
    Cancer; 1998 Nov 15; 83(10):2194-200. PubMed ID: 9827725
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Morris M, Gershenson DM, Burke TW, Kavanagh JJ, Silva EG, Wharton JT.
    Obstet Gynecol; 1990 Dec 15; 76(6):1020-4. PubMed ID: 2234710
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.